Trials / Completed
CompletedNCT04212819
Before and After Erythrocyte Suspension Transfusion
Comparison of Oxidative Stress and Asymmetric Dimethyl Arginine Levels Before and After Erythrocyte Suspension Transfusion
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Afyonkarahisar Health Sciences University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Hypoperfusion, hypoxia and ischemia occurs in circulation as a result of anemia. All of these situations lead to oxidative stress and endothelial dysfunction in the organism. In this study, the investigators aimed to investigate the oxidant-antioxidant balance and asymmetric dimethylarginine (ADMA) levels in patients that have symptomatic anemia in need of erythrocyte suspension (ES) transfusion. To the best of the investigators knowledge, there have been few studies in the literature on anemia and total oxidant, total antioxidant and ADMA levels. We aimed to observe changes in oxidative - antioxidant ADMA levels before and after ES transfusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Before Erythrocyte Suspension (ES) | ES transfusion needs of the patients were determined according to clinical signs and symptoms. Vital signs were closely monitored and recorded before, during and after transfusion. Infusion was performed slowly for the first 15 minutes in terms of allergic reaction, and then the transfusion rate was adjusted according to the patient's clinic. |
| OTHER | After Erythrocyte Suspension (ES) | Venous blood samples were obtained from patients who needed ES transfusion before transfusion. Control venous blood samples were obtained from the patients who did not develop any complications for 24 hours after starting of the transfusion and became hemodynamically stable. |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2015-04-01
- Completion
- 2015-12-31
- First posted
- 2019-12-30
- Last updated
- 2020-01-02
Source: ClinicalTrials.gov record NCT04212819. Inclusion in this directory is not an endorsement.